0001104659-21-114807.txt : 20210910 0001104659-21-114807.hdr.sgml : 20210910 20210910210100 ACCESSION NUMBER: 0001104659-21-114807 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210908 FILED AS OF DATE: 20210910 DATE AS OF CHANGE: 20210910 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bertagnolli Monica CENTRAL INDEX KEY: 0001761030 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37990 FILM NUMBER: 211248359 MAIL ADDRESS: STREET 1: C/O LEAP THERAPEUTICS, INC. STREET 2: 47 THORNDIKE STREET, SUITE B1-1 CITY: CAMBRIDGE STATE: MA ZIP: 02141 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEAP THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001509745 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 274412575 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 47 THORNDIKE STREET STREET 2: SUITE B1-1 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 252 4343 MAIL ADDRESS: STREET 1: 47 THORNDIKE STREET STREET 2: SUITE B1-1 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Dekkun Corp DATE OF NAME CHANGE: 20110107 4 1 tm2127401-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-09-08 0 0001509745 LEAP THERAPEUTICS, INC. LPTX 0001761030 Bertagnolli Monica C/O LEAP THERAPEUTICS, INC. 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02141 1 0 0 0 Stock Option (Right to Buy) 1.58 2021-09-08 4 A 0 65000 0 A 2031-09-07 Common Stock 65000 65000 D Stock Option (Right to Buy) 1.58 2021-09-08 4 A 0 16150 0 A 2031-09-07 Common Stock 16150 16150 D The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 12 equal quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of September 8, 2021, the Vesting Start Date. The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable with respect to 50% of the Option on September 30, 2021, and with respect to the remaining 50% of the Option on December 31, 2021. /s/ Douglas E. Onsi, as Attorney-in-Fact for Monica Bertagnolli 2021-09-10